Angiopoietin-Like Protein 3 (ANGPTL3) Modulates Lipoprotein Metabolism and Dyslipidemia.

Chen, Pei-Yi; Gao, Wan-Yun; Liou, Je-Wen; Lin, Ching-Yen; Wu, Ming-Jiuan; Yen, Jui-Hung

Chen, Pei-Yi; Gao, Wan-Yun; Liou, Je-Wen; Lin, Ching-Yen; Wu, Ming-Jiuan; Yen, Jui-Hung.

Afiliação

Chen PY; Center of Medical Genetics, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien 970, Taiwan.
Gao WY; Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970, Taiwan.
Liou JW; Institute of Medical Sciences, Tzu Chi University, Hualien 970, Taiwan.
Lin CY; Department of Biochemistry, School of Medicine, Tzu Chi University, Hualien 970, Taiwan.
Wu MJ; Department of Molecular Biology and Human Genetics, Tzu Chi University, Hualien 970, Taiwan.
Yen JH; Department of Biotechnology, Chia Nan University of Pharmacy and Science, Tainan 717, Taiwan.

Int J Mol Sci ; 22(14)2021 Jul 07.

Article em En | MEDLINE | ID: mdl-34298929

Assuntos

Proteínas Semelhantes a Angiopoietina/metabolismo; Dislipidemias/metabolismo; Lipoproteínas/metabolismo; Animais; Aterosclerose/metabolismo; HDL-Colesterol/metabolismo; LDL-Colesterol; Humanos; Triglicerídeos/metabolismo

Palavras-chave

ANGPTL3; ASCVDs; TG-rich lipoproteins; dyslipidemia; lipoprotein lipase

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Dislipidemias / Proteínas Semelhantes a Angiopoietina / Lipoproteínas Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Animals / Humans Idioma: En Revista: Int J Mol Sci Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Taiwan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google